Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT), reports that John A. Kollins will join the Company, effective June 1, 2012, and serve ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE